A team of life sciences and litigation & enforcement attorneys authored a June 21 article in Law360, which examined FDA final guidance on manufacturer communications. The two final guidance documents provide recommendations for communicating health care economic information and pre-approval information with payors, and for promoting information that is consistent with, but not included in, a product’s labeling. The article was written by life sciences partners Kellie Combs, Albert Cacozza, and Gregory Levine, appellate and Supreme Court partner and chair Douglas Hallward-Driemeier, and litigation & enforcement associate Emerson Siegle (all of Washington, D.C.).
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.